Report cover image

Life Science Tools Market Report and Forecast 2025-2034

Publisher Expert Market Research
Published Jul 27, 2025
Length 350 Pages
SKU # EMAR20319723

Description

The global life science tools market size was valued at USD 120.12 Billion in 2024, driven by the increased research and development activities about life science across the globe. The market size is anticipated to grow at a CAGR of 9.50% during the forecast period of 2025-2034 to achieve a value of USD 297.68 Billion by 2034.

Life Science Tools: Introduction

Life sciences is the study of living organisms and life processes. Biotechnology is the most prominent component of the life sciences. It is a toolbox that leverages the basic understanding of natural sciences to create effective solutions for various world problems. Biotechnology is used to grow food to feed families and to make medicines and vaccines to fight diseases. Researchers and scientists are turning to biotechnology to find alternatives to fossil-based fuels for a cleaner, healthier planet.

The major life science tools include microscopy instruments, molecular analysis instruments, spectroscopy instruments, chromatography instruments and flow cytometry instruments. Other instruments include mass spectrometry instruments, biotechnology instruments, imaging systems, automated liquid handling systems, clinical diagnostics instruments, and laboratory automation systems, among others.

Global Life Science Tools Market Analysis

The growth of gene and cell therapies and their rising demand is anticipated to propel the market for life science tools. Various companies have started investing more funds and efforts on accelerating their research and development for efficient gene therapies. The therapies that can potentially address the cause of disease at the genetic level, further elevating the global life science tools market growth in response to the growing demand for effective disease treatment solutions.

Gene treatments are predicted to have a positive outlook in the coming years owing to an increase in the number of FDA-approved products. Furthermore, it is anticipated that improvements in recombinant DNA technology would increase the number of active clinical trials for gene therapy.

The market has significantly benefited from developments in targeted therapy due to a better understanding of how drugs interact with patients' genetic makeup. The life science segment is currently making use of cutting-edge developments like predictive analytics to improve the production of biological treatments to keep up with the market's rising demand further propelling the global life science tools market development.

Additionally, the FDA's clearance of monoclonal antibodies for use in cancer therapy and diagnostics is expanding the uses of biologics, which is projected to further enhance the market size. The growing synergy between academics and the life sciences sector is also fueling the market growth.

Global Life Science Tools Market Segmentations

Life Science Tools Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:

Market Breakup by Technology
  • Genomic Technology
  • Proteomics Technology
  • Cell Biology Technology
  • Other Analytical and Sample Preparation Technology
  • Lab Supplies and Technologies
  • Others
Market Breakup by Product Type
  • Cell Culture Systems and 3D Cell Culture 
  
  • Instruments

    •   
  • Consumables

    •   
  • Cell and Tissue Culture Services
    • Liquid Chromatography 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Mass Spectrometry 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Flow Cytometry 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Cloning and Genome Engineering 
      
  • Kits, Reagents, and Consumables

    •   
  • Services
    • Microscopy and Electron Microscopy 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Next Generation Sequencing 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • PCR and qPCR 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Nucleic Acid Preparation 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Nucleic Acid Microarray 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Sanger Sequencing 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Transfection Devices and Gene Delivery Technologies 
      
  • Equipment

    •   
  • Reagents
    • NMR 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Other Separation Technologies 
      
  • Instruments

    •   
  • Consumables

    •   
  • Services
    • Other Products and Services 
      
  • Antibodies

    •   
  • General Supplies

    •   
  • Others

    • Market Breakup by End User
    • Government and Academic
    • Biopharmaceutical Company
    • Healthcare
    • Industrial Applications
    • Others
    Market Breakup by Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
    Global Life Science Tools Market Overview

    The market for life science tools is expanding significantly as a result of ongoing developments made by the industry's leading manufacturers in the fields of sequencing, MS, chromatography, and NMR, among other goods. The rising investments made by governments and pharmaceutical corporations in the creation of cutting-edge therapies are also aiding the growth of the market. With the rising prevalence of diseases like cancer, renal and thyroid disorders, and diabetes, there is an increased desire for novel medicines and treatments, which is projected to add further value the global life science tools market share.

    The rapid advancement of gene treatments and immunotherapies, which have shown promising results in curing diseases that were previously incurable, have been fuelling the growth of the market._x000D__x000D_

    As pharmaceutical companies continue to invest more and more intensively in their development and allocate a larger portion of their research and development budget to biologics, biopharmaceuticals made from biological sources, such as living cells, will continue to gain prominence in the forecast period.

    The growth of the market is also anticipated to be propelled by the increased collaboration between businesses, non-profit organisations, governments, and academic institutions in the development of innovative therapies and technologies.

    Life Science Tools Market: Competitor Landscape

    The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • Illumina, Inc.
    • Thermo Fisher Scientific, Inc.
    • QIAGEN N.V.
    • Merck KGaA
    • Shimadzu Corporation
    • Hitachi, Ltd.
    • Bruker Corporation
    • Oxford Instruments plc
    • Zeiss International
    *Please Note:* The report will take 5 business days to complete, after order confirmation.

    Table of Contents

    350 Pages
    1 Preface
    1.1 Objectives of the Study
    1.2 Key Assumptions
    1.3 Report Coverage – Key Segmentation and Scope
    1.4 Research Methodology
    2 Executive Summary
    3 Global Life Science Tools Market Overview
    3.1 Global Life Science Tools Market Historical Value (2018-2024)
    3.2 Global Life Science Tools Market Forecast Value (2025-2034)
    4 Global Life Science Tools Market Landscape
    4.1 Global Life Science Tools Developers Landscape
    4.1.1 Analysis by Year of Establishment
    4.1.2 Analysis by Company Size
    4.1.3 Analysis by Region
    4.2 Global Life Science Tools Product Landscape
    4.2.1 Analysis by Technology
    4.2.2 Analysis by Products
    5 Global Life Science Tools Market Dynamics
    5.1 Market Drivers and Constraints
    5.2 SWOT Analysis
    5.3 Porter’s Five Forces Model
    5.4 Key Demand Indicators
    5.5 Key Price Indicators
    5.6 Industry Events, Initiatives, and Trends
    5.7 Value Chain Analysis
    6 Global Life Science Tools Market Segmentation
    6.1 Global Life Science Tools Market by Technology
    6.1.1 Market Overview
    6.1.2 Genomic Technology
    6.1.3 Proteomics Technology
    6.1.4 Cell Biology Technology
    6.1.5 Other Analytical and Sample Preparation Technology
    6.1.6 Lab Supplies and Technologies
    6.1.7 Others
    6.2 Global Life Science Tools Market by Product Type
    6.2.1 Cell Culture Systems and 3D Cell Culture
    6.2.1.1 Instruments
    6.2.1.2 Consumables
    6.2.1.3 Cell and Tissue Culture Services
    6.2.2 Liquid Chromatography
    6.2.2.1 Instruments
    6.2.2.2 Consumables
    6.2.2.3 Services
    6.2.3 Mass Spectrometry
    6.2.3.1 Instruments
    6.2.3.2 Consumables
    6.2.3.3 Services
    6.2.4 Flow Cytometry
    6.2.4.1 Instruments
    6.2.4.2 Consumables
    6.2.4.3 Services
    6.2.5 Cloning and Genome Engineering
    6.2.5.1 Kits, Reagents, and Consumables
    6.2.5.2 Services
    6.2.6 Microscopy and Electron Microscopy
    6.2.6.1 Instruments
    6.2.6.2 Consumables
    6.2.6.3 Services
    6.2.7 Next Generation Sequencing
    6.2.7.1 Instruments
    6.2.7.2 Consumables
    6.2.7.3 Services
    6.2.8 PCR & qPCR
    6.2.8.1 Instruments
    6.2.8.2 Consumables
    6.2.8.3 Services
    6.2.9 Nucleic Acid Preparation
    6.2.9.1 Instruments
    6.2.9.2 Consumables
    6.2.9.3 Services
    6.2.10 Nucleic Acid Microarray
    6.2.10.1 Instruments
    6.2.10.2 Consumables
    6.2.10.3 Services
    6.2.11 Sanger Sequencing
    6.2.11.1 Instruments
    6.2.11.2 Consumables
    6.2.11.3 Services
    6.2.12 Transfection Devices and Gene Delivery Technologies
    6.2.12.1 Equipment
    6.2.12.2 Reagents
    6.2.13 NMR
    6.2.13.1 Instruments
    6.2.13.2 Consumables
    6.2.13.3 Services
    6.2.14 Other Separation Technologies
    6.2.14.1 Instruments
    6.2.14.2 Consumables
    6.2.14.3 Services
    6.2.15 Other Products and Services
    6.2.15.1 Antibodies
    6.2.15.2 General Supplies
    6.2.15.3 Others
    6.3 Global Life Science Tools Market by End User
    6.3.1 Market Overview
    6.3.2 Government and Academic
    6.3.3 Biopharmaceutical Company
    6.3.4 Healthcare
    6.3.5 Industrial Applications
    6.3.6 Others
    6.4 Global Life Science Tools Market by Region
    6.4.1 Market Overview
    6.4.2 North America
    6.4.3 Europe
    6.4.4 Asia Pacific
    6.4.5 Latin America
    6.4.6 Middle East and Africa
    7 North America Life Science Tools Market
    7.1 Market Share by Country
    7.2 United States of America
    7.3 Canada
    8 Europe Life Science Tools Market
    8.1 Market Share by Country
    8.2 United Kingdom
    8.3 Germany
    8.4 France
    8.5 Italy
    8.6 Others
    9 Asia Pacific Life Science Tools Market
    9.1 Market Share by Country
    9.2 China
    9.3 Japan
    9.4 India
    9.5 ASEAN
    9.6 Australia
    9.7 Others
    10 Latin America Life Science Tools Market
    10.1 Market Share by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Mexico
    10.5 Others
    11 Middle East and Africa Life Science Tools Market
    11.1 Market Share by Country
    11.2 Saudi Arabia
    11.3 United Arab Emirates
    11.4 Nigeria
    11.5 South Africa
    11.6 Others
    12 Patent Analysis
    12.1 Analysis by Type of Patent
    12.2 Analysis by Publication year
    12.3 Analysis by Issuing Authority
    12.4 Analysis by Patent Age
    12.5 Analysis by CPC Analysis
    12.6 Analysis by Patent Valuation
    12.7 Analysis by Key Players
    13 Grants Analysis
    13.1 Analysis by year
    13.2 Analysis by Amount Awarded
    13.3 Analysis by Issuing Authority
    13.4 Analysis by Grant Application
    13.5 Analysis by Funding Institute
    13.6 Analysis by NIH Departments
    13.7 Analysis by Recipient Organization
    14 Funding Analysis
    14.1 Analysis by Funding Instances
    14.2 Analysis by Type of Funding
    14.3 Analysis by Funding Amount
    14.4 Analysis by Leading Players
    14.5 Analysis by Leading Investors
    14.6 Analysis by Geography
    15 Partnership and Collaborations Analysis
    15.1 Analysis by Partnership Instances
    15.2 Analysis by Type of Partnership
    15.3 Analysis by Leading Players
    15.4 Analysis by Geography
    16 Regulatory Framework
    16.1 Regulatory Overview
    16.1.1 US FDA
    16.1.2 EU EMA
    16.1.3 INDIA CDSCO
    16.1.4 JAPAN PMDA
    16.1.5 Others
    17 Supplier Landscape
    17.1 Agilent Technologies, Inc.
    17.1.1 Financial Analysis
    17.1.2 Product Portfolio
    17.1.3 Demographic Reach and Achievements
    17.1.4 Mergers and Acquisition
    17.1.5 Certifications
    17.2 Becton, Dickinson and Company
    17.2.1 Financial Analysis
    17.2.2 Product Portfolio
    17.2.3 Demographic Reach and Achievements
    17.2.4 Mergers and Acquisition
    17.2.5 Certifications
    17.3 F. Hoffmann-La Roche Ltd.
    17.3.1 Financial Analysis
    17.3.2 Product Portfolio
    17.3.3 Demographic Reach and Achievements
    17.3.4 Mergers and Acquisition
    17.3.5 Certifications
    17.4 Bio-Rad Laboratories, Inc.
    17.4.1 Financial Analysis
    17.4.2 Product Portfolio
    17.4.3 Demographic Reach and Achievements
    17.4.4 Mergers and Acquisition
    17.4.5 Certifications
    17.5 Danaher Corporation
    17.5.1 Financial Analysis
    17.5.2 Product Portfolio
    17.5.3 Demographic Reach and Achievements
    17.5.4 Mergers and Acquisition
    17.5.5 Certifications
    17.6 Illumina, Inc.
    17.6.1 Financial Analysis
    17.6.2 Product Portfolio
    17.6.3 Demographic Reach and Achievements
    17.6.4 Mergers and Acquisition
    17.6.5 Certifications
    17.7 Thermo Fisher Scientific, Inc.
    17.7.1 Financial Analysis
    17.7.2 Product Portfolio
    17.7.3 Demographic Reach and Achievements
    17.7.4 Mergers and Acquisition
    17.7.5 Certifications
    17.8 QIAGEN N.V.
    17.8.1 Financial Analysis
    17.8.2 Product Portfolio
    17.8.3 Demographic Reach and Achievements
    17.8.4 Mergers and Acquisition
    17.8.5 Certifications
    17.9 Merck KGaA
    17.9.1 Financial Analysis
    17.9.2 Product Portfolio
    17.9.3 Demographic Reach and Achievements
    17.9.4 Mergers and Acquisition
    17.9.5 Certifications
    17.10 Shimadzu Corporation
    17.10.1 Financial Analysis
    17.10.2 Product Portfolio
    17.10.3 Demographic Reach and Achievements
    17.10.4 Mergers and Acquisition
    17.10.5 Certifications
    17.11 Hitachi, Ltd.
    17.11.1 Financial Analysis
    17.11.2 Product Portfolio
    17.11.3 Demographic Reach and Achievements
    17.11.4 Mergers and Acquisition
    17.11.5 Certifications
    17.12 Bruker Corporation
    17.12.1 Financial Analysis
    17.12.2 Product Portfolio
    17.12.3 Demographic Reach and Achievements
    17.12.4 Mergers and Acquisition
    17.12.5 Certifications
    17.13 Oxford Instruments plc
    17.13.1 Financial Analysis
    17.13.2 Product Portfolio
    17.13.3 Demographic Reach and Achievements
    17.13.4 Mergers and Acquisition
    17.13.5 Certifications
    17.14 Zeiss International
    17.14.1 Financial Analysis
    17.14.2 Product Portfolio
    17.14.3 Demographic Reach and Achievements
    17.14.4 Mergers and Acquisition
    17.14.5 Certifications
    18 Global Life Science Tools Market - Distribution Model (Additional Insight)
    18.1 Overview
    18.2 Potential Distributors
    18.3 Key Parameters for Distribution Partner Assessment
    19 Key Opinion Leaders (KOL) Insights (Additional Insight)
    20 Company Competitiveness Analysis (Additional Insight)
    20.1 Very Small Companies
    20.2 Small Companies
    20.3 Mid-Sized Companies
    20.4 Large Companies
    20.5 Very Large Companies
    21 Payment Methods (Additional Insight)
    21.1 Government Funded
    21.2 Private Insurance
    21.3 Out-of-Pocket

    Pricing

    Currency Rates
    How Do Licenses Work?

    How Do Licenses Work?

    The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

    • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

    • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

    • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

    • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

    • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

    License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

    Head shot

    Questions or Comments?

    Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
    Chat Now
    Contact Us